Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa. "Centessa is at the forefront of orexin scienc…
Adragos Pharma, a global contract development and manufacturing organization (CDMO), announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The Maisons-Alfort site is one of Europe’s largest manufacturing facilities for sterile injectables…
Global pharma major Lupin Limited announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty …
Novartis announced that it has entered into an agreement to acquire Excellergy, Inc., a private biotech company developing next-generation anti-IgE therapies for IgE-driven diseases. The proposed acquisition adds Exl-111, a half-life extended, high-affinity anti-IgE antibody in Phase 1. The acquisition builds on de…
The Global Health Innovative Technology (GHIT) Fund and Thailand Science Research and Innovation (TSRI) have signed a memorandum of understanding (MOU) to strengthen their partnership through co-funding opportunities for research and development (R&D) targeting malaria, tuberculosis, neglected tropical diseases (N…
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States. Samsung Biologics will continue supplying the …
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Transcend Therapeutics, Inc. (Transcend) announce that the two companies entered into an agreement , under which Otsuka, through its wholly owned subsidiary Otsuka America, Inc., will fully acquire Transcend. The acquisition is expected to be completed in the second quarter…
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), a commercial-stage biopharmaceutical company dedicated to developing innovative therapeutics for patients with underserved neur…
Infosys, a global leader in next-generation digital services and consulting, announced a definitive agreement to acquire Optimum Healthcare IT, recognized as a Best in KLAS healthcare digital transformation and consulting firm recognized for helping provider organizations drive large-scale transformation. The acquisi…
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd., a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.…
Page 19 of 43